Neuropeptides
Volume 44, Issue 1 , Pages 53-56, February 2010

Effect of serotonergic system on AVP secretion induced by physical exercise

Department of Internal Medicine and Biochemical Sciences, University of Parma, Parma, Italy

Graduate School in Physical Exercise and Sport Sciences, University of Parma, Parma, Italy

Cardiology Unit, Hospital of Parma, Parma, Italy

Received 13 July 2009; accepted 15 October 2009. published online 16 November 2009.

Abstract 

The present study was undertaken in order to establish the possible involvement of serotonergic receptors in the control of physical exercise-stimulated vasopressin secretion. Twenty-one healthy men (divided in three groups of seven) underwent bicycle-ergometer tests until exhaustion: exercise control test (n=21), exercise plus ondansetron, selective 5-HT3 antagonist (n=7), exercise plus buspirone, selective 5-HT1A receptor agonist (n=7), exercise plus sumatriptan, selective 5-HT1D receptor agonist (n=7). AVP levels, physiological and biochemical variables were measured and compared during tests. Results showed that exercise-induced AVP rise did not change after the administration of buspirone and sumatriptan. In contrast, the administration of ondansetron significantly reduced physical exercise-induced AVP rise. Mean peak levels during physical exercise were 4.9 times higher than basal values in the control test and 2.6 times higher than basal values in the ondansetron plus exercise test. These data demonstrate that 5-HT3 serotonergic receptors at least partially mediate the AVP response to physical exercise. On the other hand, 5-HT1A and 5-HT1D serotonergic receptors do not appear to be involved in the control of AVP secretion during exercise.

Keywords: Serotonin, AVP secretion, Physical exercise

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0143-4179(09)00113-9

doi:10.1016/j.npep.2009.10.004

Neuropeptides
Volume 44, Issue 1 , Pages 53-56, February 2010